Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
rhTPO and low-dose Rituximab for steroid-resistant/relapsed ITP
NCT01506414Phase 3Completed
- Start
- Jun 2009
- Primary completion
- Aug 2013
- Countries
- 1
01
Overview
A Phase 3 trial of recombinant human thrombopoietin in immune thrombocytopenia (ITP). Started Jun 2009; status: completed.
02
Drugs
recombinant human thrombopoietin
03
Conditions
immune thrombocytopenia (ITP)
Beyond the preview
Go deeper on NCT01506414.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01506414.